MoneyWorks4Me

The company witnessed a 22.64% growth in the revenue at Rs. 17571.60 millions for the quarter ended June 2026 as compared to Rs. 14327.50 millions during the year-ago period.Profit for the quarter ended June 2026 rises by 83.59% to Rs. 2899.60  millions from Rs. 1579.40 millions.Operating profit for the quarter ended June 2026 rose to 5191.30 millions as compared to 3489.00 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 17571.60 14327.50 22.64 17571.60 14327.50 22.64 60890.70 52169.80 16.72
Other Income 200.70 215.20 -6.74 200.70 215.20 -6.74 774.30 1004.70 -22.93
PBIDT 5191.30 3489.00 48.79 5191.30 3489.00 48.79 15156.90 10448.00 45.07
Interest 352.00 438.90 -19.80 352.00 438.90 -19.80 1429.60 1822.00 -21.54
PBDT 4839.30 3050.10 58.66 4839.30 3050.10 58.66 13727.30 8626.00 59.14
Depreciation 957.60 935.70 2.34 957.60 935.70 2.34 3786.40 3587.90 5.53
PBT 3881.70 2114.40 83.58 3881.70 2114.40 83.58 9940.90 5038.10 97.31
TAX 982.10 535.00 83.57 982.10 535.00 83.57 2536.10 1234.20 105.49
Deferred Tax -50.40 -61.60 -18.18 -50.40 -61.60 -18.18 -315.10 -304.20 3.58
PAT 2899.60 1579.40 83.59 2899.60 1579.40 83.59 7404.80 3803.90 94.66
Equity 1080.50 1079.60 0.08 1080.50 1079.60 0.08 1079.70 1078.50 0.11
PBIDTM(%) 29.54 24.35 21.32 29.54 24.35 21.32 24.89 20.03 24.29
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..